T-cell defects and postpartum depression.


Journal

Brain, behavior, and immunity
ISSN: 1090-2139
Titre abrégé: Brain Behav Immun
Pays: Netherlands
ID NLM: 8800478

Informations de publication

Date de publication:
07 2020
Historique:
received: 03 09 2019
revised: 20 12 2019
accepted: 07 01 2020
pubmed: 12 1 2020
medline: 28 4 2021
entrez: 12 1 2020
Statut: ppublish

Résumé

Most studies of immune dysregulation in perinatal mood and anxiety disorders have focused on peripheral cytokines, but literature from non-perinatal mood disorders also implicates T-cell defects. We sought to characterize proportions of T-cell subtypes in women with postpartum depression. We enrolled 21 women with postpartum depression (PPD), 39 healthy postpartum controls, and 114 healthy non-postpartum women. Blood was collected in sodium-heparin EDTA tubes and was analyzed using flow cytometry. We conducted statistical tests including linear regression analysis that were aimed at determining differences in proportions of T cell populations among groups. Mean counts of T-cells (all CD3+ T cells), T-helper cells, (CD3+CD4+ T cells), and T-cytotoxic cells (CD3+CD8+ T cells) were significantly increased in healthy postpartum women compared to healthy non-postpartum controls (p < 0.001, p = 0.007, and p = 0.002, respectively), but not in women with PPD. The increases in healthy postpartum women were driven by increases in T Our study confirms that the postpartum period in healthy women is a time of enhanced T cell activity. Women with postpartum depression failed to show physiological enhanced T-cell activity postpartum, and future research is needed to elucidate etiological mechanisms and consequences.

Sections du résumé

BACKGROUND
Most studies of immune dysregulation in perinatal mood and anxiety disorders have focused on peripheral cytokines, but literature from non-perinatal mood disorders also implicates T-cell defects. We sought to characterize proportions of T-cell subtypes in women with postpartum depression.
MATERIALS AND METHODS
We enrolled 21 women with postpartum depression (PPD), 39 healthy postpartum controls, and 114 healthy non-postpartum women. Blood was collected in sodium-heparin EDTA tubes and was analyzed using flow cytometry. We conducted statistical tests including linear regression analysis that were aimed at determining differences in proportions of T cell populations among groups.
RESULTS
Mean counts of T-cells (all CD3+ T cells), T-helper cells, (CD3+CD4+ T cells), and T-cytotoxic cells (CD3+CD8+ T cells) were significantly increased in healthy postpartum women compared to healthy non-postpartum controls (p < 0.001, p = 0.007, and p = 0.002, respectively), but not in women with PPD. The increases in healthy postpartum women were driven by increases in T
CONCLUSIONS
Our study confirms that the postpartum period in healthy women is a time of enhanced T cell activity. Women with postpartum depression failed to show physiological enhanced T-cell activity postpartum, and future research is needed to elucidate etiological mechanisms and consequences.

Identifiants

pubmed: 31926288
pii: S0889-1591(19)31153-5
doi: 10.1016/j.bbi.2020.01.007
pmc: PMC7316619
mid: NIHMS1555296
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

397-403

Subventions

Organisme : NIMH NIH HHS
ID : K23 MH110607
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Lauren M Osborne (LM)

Department of Psychiatry & Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Gynecology & Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address: lmosborne@jhmi.edu.

Janneke Gilden (J)

Department of Psychiatry, Erasmus Medical Center Rotterdam, Rotterdam, the Netherlands.

Astrid M Kamperman (AM)

Department of Psychiatry, Erasmus Medical Center Rotterdam, Rotterdam, the Netherlands.

Witte J G Hoogendijk (WJG)

Department of Psychiatry, Erasmus Medical Center Rotterdam, Rotterdam, the Netherlands.

Julie Spicer (J)

Department of Psychiatry, Icahn School of Medicine at Mt. Sinai, USA.

Hemmo A Drexhage (HA)

Department of Immunology, Erasmus Medical Center Rotterdam, Rotterdam, the Netherlands.

Veerle Bergink (V)

Department of Psychiatry, Erasmus Medical Center Rotterdam, Rotterdam, the Netherlands; Department of Psychiatry, Icahn School of Medicine at Mt. Sinai, USA; Department of Obstetrics & Gynecology, Icahn School of Medicine at Mt. Sinai, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH